Summary
The price of the weight loss drug Mounjaro in UK pharmacies is expected to increase, but Eli Lilly has made a deal to discount its price for suppliers. This means that the price rise for patients may not be as large as initially thought when buying it from private services or pharmacies. The NHS has a separate agreement, so their cost will not change.
Key Facts
- Eli Lilly plans to increase the list price of Mounjaro by 170%, affecting the highest dose.
- The highest dose was initially set to rise from £122 to £330 per month.
- With the new discount, suppliers will pay £247.50 for the highest dose.
- Patients buying the drug privately may see less than a 50% price increase.
- The NHS has an independent discounted rate, unaffected by this change.
- About 1.5 million people in the UK use weight loss drugs like Mounjaro.
- Majority of these users pay for the drug privately through pharmacies or online services.
- Eli Lilly is working with private providers to keep the drug affordable from September 1.
